- Coronavirus Disease 2019|Associated Thrombotic Microangiopathy🔍
- Coronavirus disease 2019|associated thrombotic microangiopathy ...🔍
- Systematic Review of Individual Patient Data COVID|19 Infection ...🔍
- Emerging Novel Etiology for Thrombotic Microangiopathies🔍
- Complement|Mediated Thrombotic Microangiopathy Related to ...🔍
- Coronavirus disease 2019|associated coronary endotheliitis and ...🔍
- Emerging evidence of a COVID|19 thrombotic syndrome ...🔍
- COVID|19 and thrombotic microangiopathies🔍
Coronavirus Disease 2019|Associated Thrombotic Microangiopathy
Coronavirus Disease 2019-Associated Thrombotic Microangiopathy
COVID-19-associated TMA is characterized by thrombocytopenia, hemolytic anemia, and organ failure (such as acute kidney injury).
Coronavirus disease 2019-associated thrombotic microangiopathy ...
COVID-19-associated TMA should be considered as a differential diagnosis during the COVID-19 epidemic. Excessive inflammation and severe ...
Coronavirus Disease 2019-Associated Thrombotic Microangiopathy
Infected individuals can experience a wide range of systemic complications, including thrombotic microangiopathy (TMA). Like the other forms of TMA, COVID-19- ...
Coronavirus Disease 2019-Associated Thrombotic Microangiopathy
Coronavirus disease 2019 (COVID-19) can lead to clinically significant multisystem disorders that also affect the kidney. According to recent data, ...
Coronavirus disease 2019-associated thrombotic microangiopathy ...
This case report aimed to describe the clinical course of COVID-19-associated thrombotic microangiopathy (TMA) and reviewed the comprehensive information on ...
Coronavirus Disease 2019-Associated Thrombotic Microangiopathy
Thrombotic thrombocytopenic purpura, as well as other possible known causes of typical and atypical hemolytic-uremic syndrome, was excluded. Dur ...
Systematic Review of Individual Patient Data COVID-19 Infection ...
The exact mechanisms underlying COVID-19–associated thrombotic microangiopathies (TMAs) remain incompletely understood. Herein, we present a detailed meta- ...
Systematic Review of Individual Patient Data COVID-19 Infection ...
The exact mechanisms underlying COVID-19–associated thrombotic microangiopathies (TMAs) remain incompletely understood. Herein, we present a detailed meta- ...
Emerging Novel Etiology for Thrombotic Microangiopathies: COVID ...
3 acute kidney injury in thrombotic thrombocytopenic purpura due to coronavirus disease 2019 infection after a window period of 1 month and successful ...
Complement-Mediated Thrombotic Microangiopathy Related to ...
Hannoudi, et al. A multi-center retrospective cohort study defines the spectrum of kidney pathology in coronavirus 2019 Disease (COVID-19). Kidney Int, 100 ...
Coronavirus Disease 2019-Associated Thrombotic Microangiopathy
Coronavirus Disease 2019-Associated Thrombotic Microangiopathy ... Coronavirus disease 2019 (COVID-19) has spread tremendously since its first ...
Coronavirus disease 2019-associated coronary endotheliitis and ...
This case highlights how COVID-19-associated coronary endotheliitis and thrombotic microangiopathy, in the absence of myocarditis, may induce transient severe ...
Emerging evidence of a COVID-19 thrombotic syndrome ... - Nature
Reports of widespread thromboses and disseminated intravascular coagulation (DIC) in patients with coronavirus disease 19 (COVID-19) have ...
COVID-19 and thrombotic microangiopathies - Thrombosis Research
COVID-19 infection can be associated with and complicated by the presence of thrombotic microangiopathies (TMAs).
New‐onset and relapsed thrombotic microangiopathy post‐COVID ...
Thrombotic microangiopathy (TMA) associated with coronavirus disease 2019 (COVID-19) vaccination has been reported, however, the clinical ...
Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
reporting the first published case report of thrombotic microangiopathy in a patient with coronavirus disease 2019 (COVID-19). 1. Jhaveri ...
Evidence of thrombotic microangiopathy in children with SARS-CoV ...
We enrolled 50 hospitalized pediatric patients with acute SARS-CoV-2 infection (n = 21, minimal coronavirus disease 2019 [COVID-19]; n = 11, ...
COVID‐19 associated thrombotic microangiopathy
In conclusion, TMA may be associated with COVID-19 infection. Treatment with eculizumab may be beneficial in selected patients because of the ...
No Evidence for Classic Thrombotic Microangiopathy in COVID-19
Background: Coronavirus disease-2019 (COVID-19) triggers systemic infection with involvement of the respiratory tract. There are some patients developing ...
COVID-19: a trigger for severe thrombotic microangiopathy... - Sciendo
The evidence regarding thrombotic microangiopathy (TMA) related to Coronavirus Infectious Disease 2019 (COVID-19) in patients with ...